EXHIBIT 10.3 ------------ EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (the "Agreement") is made this 31 day of August, 2002 by and between James A. McNulty ("Mr. McNulty") and BioDelivery Sciences International, Inc. (the...Executive Employment Agreement • November 15th, 2002 • Biodelivery Sciences International Inc • Blank checks • New Jersey
INTRODUCTIONContribution Agreement • January 25th, 2001 • Biodelivery Sciences International Inc • Blank checks
BIODELIVERY SCIENCES INTERNATIONAL, INC. 12,000,000 Shares of Common Stock (par value $0.001 per share) Underwriting AgreementUnderwriting Agreement • April 11th, 2019 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 10,000,000 shares of its common stock, par value $0.001 per share (the “Shares”), and Broadfin Healthcare Master Fund, Ltd. (the “Selling Shareholder”), proposes to sell to the Underwriters an aggregate of 2,000,000 Shares. The 10,000,000 Shares to be issued and sold by the Company and the 2,000,000 Shares to be sold by the Selling Shareholder are collectively referred to herein as the “Firm Shares.” In addition, the Selling Shareholder proposes to sell to the Underwriters, subject to the terms and conditions stated herein, up to an additional 1,800,000 Shares (the “Option Shares”), if and to the extent that the Representatives (as defined below) shall have determined to exercise, on behalf of the Underwriters, the right to purchase such Option Shares granted to the Underwriters in Section 3 her
FORM OFUnderwriting Agreement • May 23rd, 2002 • Biodelivery Sciences International Inc • Blank checks • New York
1 EXHIBIT 10.6 [WYETH LEDERLE VACCINES AND PEDIATRICS LETTERHEAD] March 30, 1999 Biodelivery Sciences, Inc. University Heights Science Park 111 Lock Street Newark, NJ 07103 Re: AMENDMENT TO LICENSE AGREEMENT Dear Sirs: Reference is made to the License...License Agreement • August 15th, 2001 • Biodelivery Sciences International Inc • Blank checks
LICENSE AGREEMENT BETWEEN ALBANY MEDICAL COLLEGE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY AND BIODELIVERY SCIENCES, INC. DATED AS OF SEPTEMBER 26, 1995License Agreement • August 15th, 2001 • Biodelivery Sciences International Inc • Blank checks • New Jersey
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 10th, 2014 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of February 7, 2014, between BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
CONFIDENTIAL TREATMENT REQUESTED -------------------------------- WITH RESPECT TO CERTAIN PORTIONS HEREOF --------------------------------------- DENOTED WITH "***" ------------------ Evaluation Agreement and Option to License...Confidential Treatment • November 19th, 2003 • Biodelivery Sciences International Inc • Pharmaceutical preparations
Sales AgreementBiodelivery Sciences International Inc • November 29th, 2013 • Pharmaceutical preparations • New York
BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Sales AgreementSales Agreement • July 2nd, 2015 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 20th, 2010 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 20, 2010, is by and among BioDelivery Sciences International, Inc., a Delaware corporation with offices located at 801 Corporate Center Drive, Suite #210, Raleigh, NC 27607 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
OFLimited Liability Company Operating Agreement • November 19th, 2003 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
ANDAgreement and Plan of Merger and Reorganization • August 12th, 2004 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
EXHIBIT "A" EMPLOYMENT AGREEMENT BETWEEN BIODELIVERY SCIENCES INTERNATIONAL, INC. AND FRANCIS E. O'DONNELL, MDEmployment Agreement • April 29th, 2002 • Biodelivery Sciences International Inc • Blank checks • Missouri
EXHIBIT 10.5 EXCLUSIVE LICENSE AGREEMENT This Agreement, effective as of July 1, 1996, (the Effective Date), is made by and between Lederle-Praxis Biologicals, a division of American Cyanamid Company, (hereinafter together with its parent company -...Exclusive License Agreement • August 15th, 2001 • Biodelivery Sciences International Inc • Blank checks • New Jersey
SUBLICENSE AGREEMENT This revised SUBLICENSE AGREEMENT ("Sublicense" or "Agreement") is made and entered into by BioDelivery Sciences International, Inc. and BioDelevery Sciences, Inc. (jointly referred to herein as "BDS") and RetinaPharma, Inc. f/k/a...Sublicense Agreement • March 28th, 2003 • Biodelivery Sciences International Inc • Blank checks • Missouri
Exhibit 4.1 WARRANT AGREEMENT THIS AGREEMENT is dated this ____ day of _______________, 2002, by and among BIODELIVERY SCIENCES INTERNATIONAL, INC., a Delaware corporation, having its offices at UMDNJ New Jersey Medical School, 185 Orange Avenue,...Warrant Agreement • March 26th, 2002 • Biodelivery Sciences International Inc • Blank checks • Delaware
WARRANT AGREEMENT THIS AGREEMENT is dated this ____ day of _______________, 2001, by and among BIODELIVERY SCIENCES INTERNATIONAL, INC., an Indiana corporation, having its offices at UMDNJ New Jersey Medical School, 185 Orange Avenue, Administrative...Warrant Agreement • November 7th, 2001 • Biodelivery Sciences International Inc • Blank checks • Delaware
1 2 by University. Said lease shall be for a period of five (5) years commencing on April 1, 2001.Research Agreement • August 20th, 2001 • Biodelivery Sciences International Inc • Blank checks • New Jersey
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 3rd, 2005 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, by and between the Purchaser and the Company (as amended, modified or supplemented from time to time, the “Securities Purchase Agreement”), and pursuant to the Note and the Warrants referred to therein.
AGREEMENTAgreement • April 29th, 2002 • Biodelivery Sciences International Inc • Blank checks • Florida
WITNESSETH:Stock Purchase Agreement • January 25th, 2001 • Biodelivery Sciences International Inc • Blank checks • Delaware
FIRST AMENDMENT TO SUB-LICENSE AGREEMENT BETWEEN BIODELIVERY SCIENCES INTERNATIONAL, INC. AND BIORAL NUTRIENT DELIVERY, LLCSub-License Agreement • November 19th, 2003 • Biodelivery Sciences International Inc • Pharmaceutical preparations
ContractBiodelivery Sciences International Inc • June 3rd, 2005 • Pharmaceutical preparations • New York
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO BIODELIVERY SCIENCES INTERNATIONAL, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
AGREEMENT AND PLAN OF MERGER by and among: COLLEGIUM PHARMACEUTICAL, INC., BRISTOL ACQUISITION COMPANY INC. and BIODELIVERY SCIENCES INTERNATIONAL, INC. Dated as of February 14, 2022Agreement and Plan of Merger • February 15th, 2022 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 17th, 2018 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of May 17, 2018, is by and among Biodelivery Sciences International, Inc., a Delaware corporation with headquarters located 4131 ParkLake Ave., Suite 225, Raleigh, North Carolina 27612, (the “Company”), and each of the investors listed on Schedule 1 hereto (individually, a “Buyer” and collectively, the “Buyers”).
STOCK PLEDGE AGREEMENTStock Pledge Agreement • February 25th, 2005 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
This Stock Pledge Agreement (this “Agreement”), dated as of February 22, 2005, among Laurus Master Fund, Ltd. (the “Pledgee”), BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and each of the other undersigned parties (other than the Pledgee) (the Company and each such other undersigned party, a “Pledgor” and collectively, the “Pledgors”).
RECITALS:Employment Agreement • August 20th, 2001 • Biodelivery Sciences International Inc • Blank checks • Indiana
ContractBiodelivery Sciences International Inc • June 3rd, 2005 • Pharmaceutical preparations • New York
THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS NOTE AND THE COMMON SHARES ISSUABLE UPON CONVERSION OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO BIODELIVERY SCIENCES INTERNATIONAL, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 16th, 2011 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 11, 2011, is made by and among BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and the Purchasers listed on Exhibit A hereto, together with their permitted transferees (each, a “Purchaser” and collectively, the “Purchasers”).
Exhibit 10.31 FIRST AMENDMENT TO LIMITED LIABILITY COMPANY OPERATING AGREEMENT OF BIORAL NUTRIENT DELIVERY, LLC This FIRST AMENDMENT LIMITED LIABILITY COMPANY OPERATING AGREEMENT (this "Amendment") of Bioral Nutrient Delivery, LLC, a Delaware limited...Limited Liability Company Operating Agreement • September 2nd, 2003 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
SECURITIES PURCHASE AGREEMENT LAURUS MASTER FUND, LTD. and BIODELIVERY SCIENCES INTERNATIONAL, INC. Dated: May 31, 2005Securities Purchase Agreement • June 3rd, 2005 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 31st, 2005, by and between BIODELIVERY SCIENCES INTERNATIONAL, INC., a Delaware corporation (the “Company”), and LAURUS MASTER FUND, LTD., a Cayman Islands company (the “Purchaser”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 17th, 2018 • Biodelivery Sciences International Inc • Pharmaceutical preparations
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of May 17, 2018, by and among Biodelivery Sciences International, Inc., a Delaware corporation, with headquarters located at 4131 Parklane Avenue, Suite 225, Raleigh, NC 27612 (the “Company”), and the Lead Investor (as defined below) (each a “Investor” and collectively the “Investors”, provided that, if the context requires, references to “Investors” shall be deemed to be references to “Investor”).
BIODELIVERY SCIENCES INTERNATIONAL, INC. DIRECTOR INDEMNIFICATION AGREEMENT INDEMNIFICATION AGREEMENTIndemnification Agreement • May 8th, 2018 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
This INDEMNIFICATION AGREEMENT (“Agreement”) is made as of May 2, 2018 by and between BioDelivery Sciences International, Inc., a Delaware corporation (the “Company”), and Herm Cukier (“Indemnitee”).
1 EXHIBIT 10.1 AGREEMENT OF MERGER AND PLAN OF REORGANIZATION BY AND BETWEEN BIODELIVERY SCIENCES INTERNATIONAL, INC.Agreement of Merger And • August 20th, 2001 • Biodelivery Sciences International Inc • Blank checks • Delaware
